Manufacturing solutions provider ACG group has signed a memorandum of understanding (MoU) with secure molecular technologies firm Applied DNA Sciences for the development of molecularly tagged empty hard-shell capsules.
The new products are intended to prevent counterfeit products in the pharmaceutical and nutraceutical industry by improving their authentication and traceability.
Go deeper with GlobalData
Under the deal, ACG will use Applied DNA’s SigNature molecular tagging and authentication technologies to insert a molecular tag into one or more component materials of the capsules.
A molecular tag can be specifically prepared for each customer to ensure adherence to different substrates and will be devised to facilitate authentication anywhere in the pharmaceutical supply chain.
ACG Capsules CEO Selwyn Noronha said: “With the increasing threat of counterfeits in the pharmaceutical supply chain and regulations mandating companies to deploy strategies such as serialisation and to have greater awareness, there is a need for innovative and effective solutions for product authentication, track and trace and supply chain integrity.
“The association will equip pharmaceutical companies with greater capabilities to thwart the threat of counterfeits by providing amplified traceability solution across the supply chain.”
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe new products are expected to provide companies with better capabilities during investigation of potential counterfeit medicines, as well as improve patient and regulator confidence.
Applied DNA president and CEO Dr James Hayward said: “The ability to forensically test a capsule in the field and quickly prove its provenance is a powerful tool for all nodes of the pharmaceutical supply chain and will ensure a more secure and traceable global pharmaceutical supply chain.”
